The shiitake mushroom is native to Japan, China, and other East Asian countries, where it naturally grows on fallen trees in the forest: hence the common name, “black forest mushroom.” Deliberate cultivation of shiitake, both for food and medicine, is of ancient origin.
During the Ming Dynasty period (1368-1644), shiitake developed a reputation as a “tonic,” a substance said to increase energy, prevent disease, aid convalescence from illness, and slow bodily deterioration caused by aging. It was also used more specifically to treat respiratory illnesses, liver diseases, and intestinal infestation with worms.
The soft fleshy cap (“fruiting body”) is the part used medicinally.
As yet, there are no proposed uses of shiitake mushroom or shiitake mushroom extracts that are supported by reliable scientific evidence.
Current investigation of shiitake focuses primarily on the potential immune-stimulating and anti-cancer effects of some its constituents, most prominently lentinan (LNT), a polysaccharide substance in the beta-glucan family. Limited evidence from case reports and highly preliminary human studies hints that use of intravenously injected, purified lentinan might enhance the effectiveness of chemotherapy for stomach cancer, pancreatic cancer, and ovarian cancer. 1-4Note : Do not attempt to inject lentinan products designed for oral use.
One study found hints that oral lentinan might reduce recurrence rates of genital warts following laser surgery. 11
One study failed to find oral shiitake extract helpful for treatment of prostate cancer. 14
When taken orally, shiitake mushroom is most commonly used in the form of an extract: lentinus edodes mycelium extract (LEM). The typical dose of LEM is 1-3 grams 3 times daily.
Purified lentinan suitable for intravenous use is licensed as a pharmaceutical in Japan; it is not available in the United States.
As a widely eaten food, shiitake mushroom is believed to be fairly safe. As with any food, allergic reactions can occur. 12,13
The safety of concentrated shiitake extracts, however, is less clear. Safety in pregnant or nursing women, young children, or people with severe liver or kidney disease has not been evaluated.
4. Nakano H, Namatame K, Nemoto H, et al. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology. 1999;46:2662-2668.
Last reviewed September 2014 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×